|
Pins, G D; Toner, M; Morgan, J R (2000) Microfabrication of an analog of the basal lamina: biocompatible membranes with complex topographies. FASEB J 14:593-602
|
|
Eming, S A; Whitsitt, J S; He, L et al. (1999) Particle-mediated gene transfer of PDGF isoforms promotes wound repair. J Invest Dermatol 112:297-302
|
|
Le Doux, J M; Morgan, J R; Yarmush, M L (1999) Differential inhibition of retrovirus transduction by proteoglycans and free glycosaminoglycans. Biotechnol Prog 15:397-406
|
|
Le Doux, J M; Davis, H E; Morgan, J R et al. (1999) Kinetics of retrovirus production and decay. Biotechnol Bioeng 63:654-62
|
|
Eming, S A; Medalie, D A; Tompkins, R G et al. (1998) Genetically modified human keratinocytes overexpressing PDGF-A enhance the performance of a composite skin graft. Hum Gene Ther 9:529-39
|
|
Le Doux, J M; Morgan, J R; Yarmush, M L (1998) Removal of proteoglycans increases efficiency of retroviral gene transfer. Biotechnol Bioeng 58:23-34
|
|
Medalie, D A; Tompkins, R G; Morgan, J R (1998) Characterization of a composite tissue model that supports clonal growth of human melanocytes in vitro and in vivo. J Invest Dermatol 111:810-6
|
|
Eming, S A; Morgan, J R; Berger, A (1997) Gene therapy for tissue repair: approaches and prospects. Br J Plast Surg 50:491-500
|
|
Medalie, D A; Eming, S A; Collins, M E et al. (1997) Differences in dermal analogs influence subsequent pigmentation, epidermal differentiation, basement membrane, and rete ridge formation of transplanted composite skin grafts. Transplantation 64:454-65
|
|
Le Doux, J M; Morgan, J R; Snow, R G et al. (1996) Proteoglycans secreted by packaging cell lines inhibit retrovirus infection. J Virol 70:6468-73
|
Showing the most recent 10 out of 15 publications
